trial · primary record
Amivantamab
Squamous Cell Carcinoma of Head and Neck
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 600 |
| Primary completion | 2029-07-18 |
| Primary endpoint | Overall Survival (OS) |
| Registry ID | NCT07276399 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:42.024Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07276399
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Amivantamab · compound